Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 33-41

  Patil, N S ^a   Hall, F C ^a   Drover, S ^a   Spurrell, D R ^a   Bos, E ^a   Cope, A P ^a   Sonderstrup, G ^a   Mellins, E D ^a  

^a Ctr for Clinical Sci Res Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; EPITOPE; GLYCOPROTEIN GP 39; HLA DM ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC ASSOCIATION; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOLOGICAL TOLERANCE; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

EID: 0035165288     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.33     Document Type: Article

References (62)

1. Breakdown of self-tolerance and the pathogenesis of autoimmunity
2. A new look at MHC and autoimmune disease
3. Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases
4. A molecular basis for MHC class II-associated autoimmunity
5. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris
6. HLA and disease 1982-a survey
7. Developing and shedding inhibitions: How MHC class II molecules reach maturity
8. Accessory molecules of MHC class II peptide loading
9. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules
10. Mediation by HLA-DM of dissociation of peptides from HLA-DR
11. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM
12. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
13. An autoantigenic T cell epitope forms unstable complexes with class II MHC: A novel route for escape from tolerance induction
14. Myelin basic protein peptide Complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH
15. Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity
16. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants
17. T cell epitopes of insulin defined in HLA-DR4-transgenic mice are derived from preproinsulin and proinsulin
18. The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire
19. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes
20. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor
21. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping
22. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
23. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: Results from a large, population-based study
24. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
25. The molecular basis of susceptibility to rheumatoid arthritis
26. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II
27. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II
28. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly
29. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family
30. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family
31. A new biochemical marker for joint injury: Analysis of YKL-40 in serum and synovial fluid
32. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity
33. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis
34. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles
35. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: Mutational analysis
36. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules
37. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides
38. Novel glycosylation of HLA-DRα disrupts antigen presentation without altering endosomal localization
39. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes
40. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response
41. Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome
42. Analysis of monoclonal antibodies specific for unique and shared determinants on HLA-DR4 molecules
43. Two populations of Ia-like molecules on a human B cell line
44. Modulation of peptide-dependent allospecific epitopes on HLA-DR4 molecules by HLA-DM
45. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells
46. Detection of peptide-MHC class II complexes on the surface of intact cells
47. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
48. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (α1*0101,β1*0401)-transgenic mice
49. Exogenously provided peptides fail to complex with intracellular class II molecules for presentation by antigen-presenting cells
50. Dominance and crypticity of T cell antigenic determinants
51. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
52. Editing of the HLA-DR-peptide repertoire by HLA-DM
53. Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation
54. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides
55. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules
56. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH
57. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion
58. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing
59. Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex
60. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation
61. Crystal structure of mouse H2-M
62. HLA-DMB expression by thyrocytes: Indication of the antigen-processing and possible presenting capability of thyroid cells